Correlation Between Revolution Medicines and Enanta Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Revolution Medicines and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Enanta Pharmaceuticals.

Diversification Opportunities for Revolution Medicines and Enanta Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Revolution and Enanta is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Enanta Pharmaceuticals go up and down completely randomly.

Pair Corralation between Revolution Medicines and Enanta Pharmaceuticals

Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.94 times more return on investment than Enanta Pharmaceuticals. However, Revolution Medicines is 1.06 times less risky than Enanta Pharmaceuticals. It trades about 0.22 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest  4,156  in Revolution Medicines on September 1, 2024 and sell it today you would earn a total of  1,629  from holding Revolution Medicines or generate 39.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Revolution Medicines  vs.  Enanta Pharmaceuticals

 Performance 
       Timeline  
Revolution Medicines 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.
Enanta Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enanta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Revolution Medicines and Enanta Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revolution Medicines and Enanta Pharmaceuticals

The main advantage of trading using opposite Revolution Medicines and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.
The idea behind Revolution Medicines and Enanta Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments